Submit Deal

Announced

14 Nov 2025

Lundbeck to acquire Avadel for $2.2bn.

Synopsis

Lundbeck, a Danish international pharmaceutical company, offered to acquire Avadel, a biopharmaceutical company, for $2.2bn.

Principals

target

Avadel Pharmaceuticals

bidder

Lundbeck As

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

morgan stanley

HQ - New York

financial advisors

target

2184

Deals

£ 6,364.39 B

Total Value

goldman sachs

HQ - New York

financial advisors

target

2555

Deals

£ 7,641.60 B

Total Value

goodwin procter

HQ - Boston

legal advisors

target

1038

Deals

£ 620.00 B

Total Value

arthur cox

HQ - Dublin, Ireland

legal advisors

target

116

Deals

£ 256.91 B

Total Value

precision aq

HQ - New York

pr advisors

target

Deals

£ 22.68 B

Total Value